Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)

计划入组 150 人 · 首次发布于 2025 年 12 月 22 日

Influence of IgA Nephropathy ? Prescription on Serum Gd-IgA1 and BAFF level for Patients with IgA Nephropathy

IgA Nephropathy, Lymphocyte Homing and IgA Class Switch

计划入组 72 人 · 首次发布于 2013 年 1 月 25 日

IgA proteases(IGAN Biosciences)

ImmTOR + IgA protease (autoimmune dusease/IgA nephropathy)

sIgA immunotherapy (Secretory IgA)

Calliditas Therapeutics

Sweden

Fox Ira

Israel

INA RESPOND

Indonesia

FDA Clears IND for Alebund's First-in-Class IgA Protease AP308 in IgA Nephropathy

Felzartamab Shows Promise in Reducing Proteinuria in IgA Nephropathy Patients

Phase II Study Shows Atacicept's Potential in Treating IgA Nephropathy